X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (15932) 15932
Newsletter (3094) 3094
Book Review (2420) 2420
Publication (878) 878
Newspaper Article (849) 849
Conference Proceeding (297) 297
Magazine Article (211) 211
Book Chapter (186) 186
Trade Publication Article (98) 98
Dissertation (38) 38
Web Resource (15) 15
Paper (9) 9
Book / eBook (8) 8
Journal / eJournal (2) 2
Data Set (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
ace inhibitors (12172) 12172
index medicus (9639) 9639
humans (7016) 7016
male (4915) 4915
angiotensin (4656) 4656
hypertension (4471) 4471
female (3727) 3727
animals (3272) 3272
angiotensin-converting enzyme inhibitors - therapeutic use (3083) 3083
research (2803) 2803
enzymes (2786) 2786
middle aged (2617) 2617
cardiac & cardiovascular systems (2295) 2295
aged (2210) 2210
drug therapy (2067) 2067
pharmacology & pharmacy (2009) 2009
heart failure (1977) 1977
angiotensin-converting enzyme inhibitors - pharmacology (1909) 1909
rats (1829) 1829
risk factors (1738) 1738
ace-inhibitors (1685) 1685
adult (1660) 1660
hypertension - drug therapy (1623) 1623
blood-pressure (1461) 1461
care and treatment (1447) 1447
blood pressure (1432) 1432
ace inhibitor (1418) 1418
peripheral vascular disease (1402) 1402
mortality (1391) 1391
health aspects (1369) 1369
abridged index medicus (1335) 1335
captopril (1311) 1311
analysis (1302) 1302
blood pressure - drug effects (1294) 1294
diabetes (1283) 1283
angiotensin-converting enzyme (1272) 1272
ace (1269) 1269
medical research (1219) 1219
reports (1183) 1183
urology & nephrology (1149) 1149
physiological aspects (1057) 1057
renin-angiotensin system (1046) 1046
medicine, general & internal (1037) 1037
enalapril (1016) 1016
medicine, experimental (988) 988
drugs (949) 949
antihypertensive agents - therapeutic use (925) 925
treatment outcome (917) 917
physiology (912) 912
peptides (911) 911
peptidyl-dipeptidase a - genetics (901) 901
ace-inhibition (893) 893
angiotensin-converting enzyme inhibitors - adverse effects (885) 885
cardiovascular disease (835) 835
heart failure - drug therapy (835) 835
myocardial-infarction (826) 826
renin-angiotensin system - drug effects (823) 823
drug therapy, combination (822) 822
medicine & public health (818) 818
angiotensin converting enzyme (798) 798
genetic aspects (774) 774
antihypertensive drugs (773) 773
proteins (770) 770
cardiology (764) 764
food science & technology (759) 759
cardiac patients (758) 758
angiotensin-converting enzyme inhibitors - administration & dosage (745) 745
diuretics (745) 745
cardiovascular agents (744) 744
prevention (741) 741
kidney diseases (739) 739
dosage and administration (734) 734
peptidyl-dipeptidase a - metabolism (732) 732
bradykinin (726) 726
angiotensin-converting enzyme inhibitors (684) 684
disease (684) 684
hypertension - physiopathology (678) 678
angiotensin ii (665) 665
rodents (660) 660
system (653) 653
heart-failure (646) 646
proteinuria (642) 642
risk (638) 638
heart (623) 623
therapy (614) 614
studies (612) 612
aged, 80 and over (611) 611
time factors (597) 597
biochemistry & molecular biology (594) 594
ace-inhibitor (581) 581
universities and colleges (568) 568
expression (566) 566
heart attacks (559) 559
internal medicine (556) 556
ace inhibition (546) 546
dose-response relationship, drug (544) 544
converting enzyme-inhibitors (537) 537
clinical trials (530) 530
mice (529) 529
usage (528) 528
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (19525) 19525
German (362) 362
Russian (147) 147
French (82) 82
Spanish (66) 66
Japanese (62) 62
Italian (44) 44
Czech (43) 43
Korean (35) 35
Chinese (34) 34
Portuguese (22) 22
Polish (17) 17
Hungarian (14) 14
Slovak (13) 13
Croatian (6) 6
Turkish (4) 4
Indonesian (3) 3
Serbian (3) 3
Slovenian (3) 3
Bosnian (2) 2
Dutch (2) 2
Persian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Liver International, ISSN 1478-3223, 04/2015, Volume 35, Issue 4, pp. 1451 - 1463
Background & AimsMammalian target of rapamycin and angiotensin-converting enzyme inhibition has been shown to have antifibrotic activity in models of liver... 
inhibitors | | fibrosis | ACE | Mdr2 | TOR | MTOR inhibitors | ACE inhibitors | Fibrosis | RAPAMYCIN | BILE-DUCT | LIVER FIBROSIS | BILIARY FIBROSIS | HEPATIC-FIBROSIS | P-GLYCOPROTEIN | IN-VITRO | SCLEROSING CHOLANGITIS | mTOR inhibitors | SMOOTH-MUSCLE-CELLS | GASTROENTEROLOGY & HEPATOLOGY | SIROLIMUS | Liver - pathology | Liver - enzymology | Tetrazoles - pharmacology | Captopril - pharmacology | Species Specificity | TOR Serine-Threonine Kinases - metabolism | ATP Binding Cassette Transporter, Sub-Family B - deficiency | Male | Liver Cirrhosis, Experimental - drug therapy | Angiotensin II Type 1 Receptor Blockers - pharmacology | TOR Serine-Threonine Kinases - antagonists & inhibitors | Liver Cirrhosis, Experimental - enzymology | Biphenyl Compounds - pharmacology | Liver - drug effects | Time Factors | Liver Cirrhosis, Experimental - pathology | Female | Angiotensin-Converting Enzyme Inhibitors - pharmacology | Drug Therapy, Combination | Everolimus - pharmacology | Hydroxyproline - metabolism | Gene Expression Regulation | Liver Cirrhosis, Experimental - genetics | Sirolimus - pharmacology | Mice, Knockout | Animals | Signal Transduction - drug effects | Renin-Angiotensin System - drug effects | Protein Kinase Inhibitors - pharmacology | ATP Binding Cassette Transporter, Sub-Family B - genetics | Liver diseases | Captopril | Analysis | Angiotensin | Genetic research | Gene expression | Index Medicus
Journal Article
Journal Article
European Journal of Epidemiology, ISSN 0393-2990, 1/2014, Volume 29, Issue 10, pp. 767 - 775
The heterogeneity in case-control studies on the associations between community-acquired pneumonia (CAP) and ACE-inhibitors (ACEi), statins, and proton pump... 
PHARMACO-EPIDEMIOLOGY | Case control studies | Prescription drugs | Pneumonia | Databases | Primary health care | Hospital administration | General practice | Proton pump inhibitors | Medications | Drug prescriptions | Public Health | Medicine & Public Health | Community acquired pneumonia | Case–control | Infectious Diseases | Oncology | Cardiology | Epidemiology | Ace-inhibitors | Statins | Epidemiology methods | Case-control | MORTALITY | PROJECT | METAANALYSIS | BIAS | VALIDATION | ENZYME INSERTION/DELETION POLYMORPHISM | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | THERAPY | DRUGS | COHORT | COMMUNITY-ACQUIRED-PNEUMONIA | Community-Acquired Infections - etiology | Community-Acquired Infections - epidemiology | Humans | Middle Aged | Netherlands - epidemiology | Pneumonia - prevention & control | Male | Case-Control Studies | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Aged, 80 and over | Adult | Female | Odds Ratio | Proton Pump Inhibitors - adverse effects | Pneumonia - etiology | Risk Assessment | Pneumonia - epidemiology | Risk Factors | Logistic Models | Treatment Outcome | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Adolescent | Aged | Community-Acquired Infections - prevention & control | Population Surveillance | Bacterial pneumonia | Pharmacy | Risk factors | ACE inhibitors | Antacids | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2017, Volume 377, Issue 18, pp. 1733 - 1745
Adolescents with type 1 diabetes received one of four regimens: angiotensin-converting–enzyme (ACE) inhibitor–placebo, statin–placebo, ACE inhibitor–statin, or... 
INTIMA-MEDIA THICKNESS | C-REACTIVE PROTEIN | MEDICINE, GENERAL & INTERNAL | INTERVENTION TRIAL ADDIT | CONVERTING-ENZYME-INHIBITOR | GLUCOSE CONTROL | ALBUMIN EXCRETION | HIGH-RISK | MICROALBUMINURIA | YOUNG-PEOPLE | FOLLOW-UP | Albuminuria - etiology | Double-Blind Method | Area Under Curve | Humans | Male | Diabetes Mellitus, Type 1 - complications | Albuminuria - prevention & control | Creatinine - urine | Diabetes Mellitus, Type 1 - urine | Diabetes Mellitus, Type 1 - drug therapy | Medication Adherence | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Diabetes Mellitus, Type 1 - blood | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Lipids - blood | Adolescent | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Female | Drug Therapy, Combination | Child | Type 1 diabetes | Patient outcomes | Analysis | Outcome and process assessment (Health Care) | Dosage and administration | Drug therapy | ACE inhibitors | Statins | Creatinine | Adolescence | Puberty | Enzymes | C-reactive protein | Diabetes mellitus | Albumin | Triglycerides | Apolipoproteins | Cholesterol | Risk factors | Glomerular filtration rate | Apolipoprotein B | Peptidyl-dipeptidase A | Angiotensin | Teenagers | Diabetes | Cardiovascular diseases | Drug dosages | Age | Endocrinology | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
EUROPEAN HEART JOURNAL, ISSN 0195-668X, 08/2012, Volume 33, Issue 16, pp. 2088 - 2097
Reninangiotensinaldosterone system (RAAS) inhibitors are well established for the reduction in cardiovascular morbidity, but their impact on all-cause... 
Hypertension | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | CARDIOVASCULAR EVENTS | Mortality | RECEPTOR BLOCKERS | HEART-FAILURE | BLOOD-PRESSURE | SECONDARY PREVENTION | Meta-analysis | ARB | MORBIDITY | HIGH-RISK | DOUBLE-BLIND | ACE inhibitor | CORONARY-ARTERY-DISEASE
Journal Article
Journal Article